Lonza | LONN - Ebit

Stock Price
529.60
Daily Change
4.60 0.88%
Monthly
-1.12%
Yearly
-11.38%
Q1 Forecast
512.24

Lonza reported CHF673M in EBIT for its fiscal semester ending in June of 2025.





Ebit Change Date
Akzo Nobel EUR 297M 6M Sep/2025
Alcon AG USD 334M 84M Sep/2025
Almirall EUR 43.02M 28.78M Jun/2025
AstraZeneca USD -1.5B 5.01B Sep/2025
BASF EUR 493M 334M Sep/2025
Bayer EUR -399M 363M Sep/2025
Beiersdorf EUR 816M 370M Jun/2025
Covestro EUR 5.39B 5.34B Sep/2025
Demant DKK 1.87B 471M Jun/2025
Fresenius EUR 574M 14M Sep/2025
Fresenius Medical Care EUR 449.94M 18.94M Sep/2025
Geberit CHF 195.5M 42.2M Jun/2025
Genmab DKK 432M 900.27M Jun/2025
Givaudan CHF 756M 221M Jun/2024
GlaxoSmithKline GBP 2.79B 716M Sep/2025
GN Store Nord DKK 340M 121M Sep/2025
Hikma Pharmaceutical USD 317M 85M Dec/2024
Johnson Matthey GBP 142M 89M Dec/2025
Merck EUR 1.21B 180M Sep/2025
Novartis USD -9.19B 13.87B Jun/2025
Philips EUR 329M 159M Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sika AG CHF 798.1M 93.6M Jun/2025
Smith & Nephew USD 440M 50M Dec/2025
Solvay EUR 44M 106M Jun/2025
UCB EUR 502M 168M Dec/2024